YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Peripheral Blood Monocytes in Multiple Sclerosis Exacerbations

dc.authorscopusid 35564273500
dc.authorscopusid 6701642517
dc.authorscopusid 6701669939
dc.contributor.author Tombul, Temet
dc.contributor.author Anlar, Omer
dc.contributor.author Akdeniz, Hayrettin
dc.date.accessioned 2025-05-10T17:48:32Z
dc.date.available 2025-05-10T17:48:32Z
dc.date.issued 2011
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp [Akdeniz, Hayrettin] Yuzuncu Yil Univ, Dept Infect Dis, Sch Med, TR-65200 Van, Turkey; [Anlar, Omer] Rize Univ, Sch Med, Dept Neurol, Rize, Turkey; [Tombul, Temet] Yuzuncu Yil Univ, Dept Neurol, Sch Med, TR-65200 Van, Turkey en_US
dc.description.abstract Objectives: Monocytes (MO), macrophages, and microglia have a central role in the central nervous system inflammation of multiple sclerosis (MS). During clinical activity in MS, MO activation markers increase and some interleukins and tumor necrosis factor-alpha levels are elevated. Our aim was to determine levels of absolute MO count and percentage in peripheral blood of MS patients during the attacks. Methodology: We assessed the percentage of MO by examining the blood smears in 28 patients with definite MS, in 20 patients with acute cerebrovascular disease (CVD) and in 20 healthy control subjects. Results: The mean value of absolute MO count in MS patients, CVD and control groups were as 606.67 +/- 170.52, 746.50 +/- 414.76 and 360.00 +/- 109.54 respectively. The mean values of MO percentage in MS patients, CVD and control group were 8.34 +/- 2.61%, 5.56 +/- 2.48% and 5.36 +/- 1.50% respectively. The mean percentage of MO was significantly elevated in MS patients compared with the both groups of CVD and control (P < 0.001). Conclusion: Our results suggest a possible role of an increase in MO activation in the acute exacerbations of Multiple Sclerosis. en_US
dc.description.woscitationindex Science Citation Index Expanded
dc.identifier.endpage 76 en_US
dc.identifier.issn 1682-024X
dc.identifier.issue 1 en_US
dc.identifier.scopus 2-s2.0-79551564857
dc.identifier.scopusquality Q1
dc.identifier.startpage 73 en_US
dc.identifier.uri https://hdl.handle.net/20.500.14720/17136
dc.identifier.volume 27 en_US
dc.identifier.wos WOS:000287892300017
dc.identifier.wosquality Q3
dc.language.iso en en_US
dc.publisher Professional Medical Publications en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Peripheral Blood en_US
dc.subject Monocytes en_US
dc.subject Multiple Sclerosis en_US
dc.subject Exacerbation en_US
dc.title Peripheral Blood Monocytes in Multiple Sclerosis Exacerbations en_US
dc.type Article en_US

Files